Opportunity Information: Apply for PAR 13 222
Apply for PAR 13 222
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "NIDA Research Center of Excellence Grant Program (P50)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on May 6, 2013 and posted on May 6, 2013.
- Applicants must submit their applications by Jan 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: For profit organizations other than small businesses State governments Native American tribal governments (Federally recognized) Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIDA Research Center of Excellence Grant Program (P50) is a National Institutes of Health (NIH) funding opportunity designed to support large, multidisciplinary research centers focused on drug abuse and addiction. The program, issued by the National Institute on Drug Abuse (NIDA), seeks to fund centers that do more than run a collection of related projects. The expectation is that each funded center will pursue bold, highly innovative science that can meaningfully shift understanding in the areas it studies. NIDA makes it clear that incremental or routine extensions of existing work are not the goal; instead, applicants are expected to propose new and creative research directions that can transform the field.
A central feature of this opportunity is the emphasis on integration and synergy. A competitive P50 Center of Excellence is expected to be thematically unified, with multiple disciplines working together in a coordinated way so the whole center produces insights and capabilities that individual projects could not achieve on their own. In practical terms, this means the research portfolio should be deliberately designed to connect methods, expertise, and data across projects, creating a cohesive program rather than isolated efforts. The scientific scope can fall anywhere within NIDA's mission, as long as the overall center is grounded in outstanding, innovative drug abuse and addiction research.
Beyond research, the FOA expects centers to operate as national resources. That includes providing educational and outreach activities that serve the broader drug abuse research community, educational organizations, the general public, and policy makers working in NIDA-relevant areas. The intent is that each center contributes to the national infrastructure for addiction science by sharing what it learns and building connections between researchers and stakeholders who use or are affected by the evidence base. Consistent with that resource role, the program also highlights sharing of findings, data, and other resources as a core goal, with the broader purpose of accelerating progress across the field rather than keeping advances confined within a single institution.
Another major priority is developing the next generation of investigators. The P50 Center of Excellence mechanism is expected to support education, training, and mentoring, with new investigators receiving meaningful roles in center projects. This language signals that early-stage or emerging researchers should not be added as an afterthought; they are expected to be substantively integrated into the center's work in ways that build their independence, skills, and research trajectory within addiction science.
Administratively, this opportunity is a discretionary grant program under the NIH, categorized under education and health-related funding activities, and tied to CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The funding opportunity number is PAR-13-222, posted May 6, 2013, with an original and final closing date of January 7, 2016, and an archive date of February 7, 2016, indicating the announcement is no longer active for new applications. The FOA does not require cost sharing or matching funds.
Eligibility is broad across U.S.-based organizations and government entities. Eligible applicants include public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, with the noted exception category referencing non-IHE organizations), for-profit organizations (including small businesses), state and local governments (such as city/township, county, special districts, and independent school districts), public housing authorities/Indian housing authorities, and federally recognized tribal governments as well as other tribal organizations. The eligibility section also explicitly mentions categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations and certain eligible federal agencies. Foreign institutions and other non-U.S. entities are not eligible, and the FOA also bars non-domestic components of U.S. organizations and foreign components as defined by NIH policy.
For applicants seeking the official announcement details, the FOA directs readers to the NIH Grants Guide entry associated with PAR-13-222. It also provides NIH Office of Extramural Research (OER) webmaster contact information for access or linking issues, reflecting standard NIH support for technical problems with the electronic posting rather than programmatic questions.
FAQs: NIDA Research Center of Excellence Grant Program (P50) - PAR-13-222
What is the NIDA Research Center of Excellence Grant Program (P50)?
It is a National Institutes of Health (NIH) funding opportunity from the National Institute on Drug Abuse (NIDA) designed to support large, multidisciplinary research centers focused on drug abuse and addiction.
What is the main purpose of this P50 Center of Excellence program?
The program is intended to fund centers that pursue bold, highly innovative science that can meaningfully shift understanding in areas relevant to drug abuse and addiction. It is not intended to fund routine or incremental extensions of existing work.
Does NIDA expect this to be a group of separate projects or a unified center?
NIDA expects a thematically unified center with integration and synergy across multiple disciplines. The center should be deliberately designed so the overall program produces insights and capabilities that individual projects could not achieve on their own.
What does "integration and synergy" mean in practical terms for the center design?
It means the research portfolio should connect methods, expertise, and data across projects in a coordinated way, creating a cohesive program rather than isolated efforts.
What scientific areas are allowed under this funding opportunity?
The scientific scope can fall anywhere within NIDA's mission, as long as the overall center is grounded in outstanding, innovative drug abuse and addiction research.
Are incremental or routine extensions of existing work competitive under this program?
No. NIDA explicitly indicates that incremental or routine extensions are not the goal; applicants are expected to propose new and creative research directions that can transform the field.
Beyond research, what additional roles are centers expected to serve?
Centers are expected to operate as national resources by providing educational and outreach activities that serve the broader drug abuse research community, educational organizations, the general public, and policy makers working in NIDA-relevant areas.
Who are the intended audiences for the required educational and outreach activities?
The FOA describes audiences that include the broader drug abuse research community, educational organizations, the general public, and policy makers working in areas relevant to NIDA.
What does the FOA say about sharing data and research resources?
Sharing of findings, data, and other resources is highlighted as a core goal, with the broader purpose of accelerating progress across the field rather than keeping advances confined within a single institution.
How does this program address training and career development?
Developing the next generation of investigators is described as a major priority. The center is expected to support education, training, and mentoring, with new investigators receiving meaningful roles in center projects.
Do early-stage or emerging researchers need to have substantive roles in the center?
Yes. The FOA indicates that new investigators should not be added as an afterthought; they are expected to be substantively integrated into the center's work in ways that build independence, skills, and research trajectory within addiction science.
What type of grant program is this administratively?
It is a discretionary grant program under the NIH, categorized under education and health-related funding activities.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs).
What is the funding opportunity number (FOA number)?
The FOA number is PAR-13-222.
When was this FOA posted, and is it still open?
It was posted May 6, 2013, with an original and final closing date of January 7, 2016. The archive date is February 7, 2016, indicating the announcement is no longer active for new applications.
Is cost sharing or matching required?
No. The FOA states that cost sharing or matching funds are not required.
Who is eligible to apply?
Eligibility is broad across U.S.-based organizations and government entities. Eligible applicants include public and private institutions of higher education; nonprofits (with and without 501(c)(3) status, with the noted exception category referencing non-IHE organizations); for-profit organizations (including small businesses); state and local governments (including city/township, county, special districts, and independent school districts); public housing authorities/Indian housing authorities; federally recognized tribal governments; and other tribal organizations.
Are minority-serving institutions specifically noted as eligible?
Yes. The eligibility section explicitly mentions categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American and Native American Pacific Islander Serving Institutions (AANAPISIs).
Are faith-based and community-based organizations eligible?
Yes. The eligibility section includes faith-based or community-based organizations.
Are any federal agencies eligible to apply?
Yes. The eligibility section mentions certain eligible federal agencies.
Are foreign institutions or non-U.S. entities eligible to apply?
No. Foreign institutions and other non-U.S. entities are not eligible under this FOA.
Can a U.S. organization include a non-domestic (foreign) component in its application?
No. The FOA bars non-domestic components of U.S. organizations and foreign components as defined by NIH policy.
Where can applicants find the official FOA announcement details?
The FOA directs readers to the NIH Grants Guide entry associated with PAR-13-222.
Who should be contacted for technical issues accessing or linking to the FOA posting?
The FOA provides NIH Office of Extramural Research (OER) webmaster contact information for access or linking issues, reflecting support for technical problems with the electronic posting rather than programmatic questions.
Browse more opportunities from the same category: Education Health
Next opportunity: Integrated Cybersecurity Education Communities (ICEC) Expansion of a Portable Cybersecurity Education Teacher Focused Model
Previous opportunity: Archaeological Investigations, Fort Clark Irrigation District
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 222
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 222) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 14 008 Funding Number: RFA DA 14 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Integrating Substance Abuse Prevention and Treatment within HIV/AIDS Service Delivery Settings (R01) Apply for RFA DA 14 011 Funding Number: RFA DA 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| HIV/AIDS and Substance Use among Black/African American Women and Young MSM (R01) Apply for RFA DA 14 010 Funding Number: RFA DA 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV/AIDS and Substance Use Among the Homeless and Unstably Housed (R01) Apply for RFA DA 14 009 Funding Number: RFA DA 14 009 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comorbid HIV, Chronic Pain, and Substance Use among Older Adults (R21) Apply for RFA DA 14 012 Funding Number: RFA DA 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R21) Apply for PA 13 246 Funding Number: PA 13 246 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R03) Apply for PA 13 247 Funding Number: PA 13 247 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R01) Apply for PA 13 248 Funding Number: PA 13 248 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition Adult Brain Tumor Consortium (ABTC) (UM1) Apply for RFA CA 13 501 Funding Number: RFA CA 13 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Limited Competition Pediatric Brain Tumor Consortium (UM1) Apply for RFA CA 13 502 Funding Number: RFA CA 13 502 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,590,000 |
| Clinical Trials and Interventional Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01) Apply for RFA AT 14 003 Funding Number: RFA AT 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Pilot and Feasibility Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R34) Apply for RFA AT 14 004 Funding Number: RFA AT 14 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Health Services and Observational Studies of Non Pharmacological Approaches to Managing Pain and Co Morbid Conditions in U.S. Military Personnel, Veterans, and their Families (R01) Apply for RFA AT 14 005 Funding Number: RFA AT 14 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Program Project Grant Applications (P01) Apply for PAR 13 259 Funding Number: PAR 13 259 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Synergizing Omic and Symptom Science (R15) Apply for PA 13 265 Funding Number: PA 13 265 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Synergizing Omic and Symptom Science (R01) Apply for PA 13 264 Funding Number: PA 13 264 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Grand Opportunity in Medications Development for Substance Use Disorders (U01) Apply for PAR 13 270 Funding Number: PAR 13 270 Agency: National Institutes of Health Category: Education Health Funding Amount: $5,000,000 |
| Revision Applications to Promote Collaborative Research on Addiction at NIH (CRAN) Comorbidity Related Research (R01) Apply for RFA DA 14 014 Funding Number: RFA DA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Administrative Supplements to Promote Collaborative Research on Addiction at NIH (CRAN) Comorbidity Related Research (Admin Supp) Apply for PA 13 275 Funding Number: PA 13 275 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Abuse Resistant and Abuse Deterrent Formulations and Devices to Avoid the Abuse, Misuse and Diversion of Prescription Opioids by Patients (SBIR)(R43/R44) Apply for RFA DA 14 013 Funding Number: RFA DA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 222", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.